New hope for cancer patients: drug may fix dangerous low platelets from radiation combo therapy
NCT ID NCT07128576
First seen Nov 01, 2025 · Last updated Jun 04, 2026 · Updated 33 times
Summary
This study tests a drug called romiplostim N01 in 60 adults with solid tumors who have low platelets after radiation combined with other cancer treatments. The goal is to see if the drug can safely raise platelet counts and reduce the need for transfusions. It is a phase 2 trial, meaning it checks both safety and how well the drug works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.